Proportion of trans uretrale prostatectomy for benign hyperplasia on total of of prostatectomy

There are several treatment options for the treatment of benign prostatic hyperplasia: pharmacological treatment, aimed at improving the quality of life alleviating symptoms dysuria, watchful waiting (watchful waiting) for patients at low risk of disease progression and surgical treatment, usually a transurethral prostatectomy (TURP). The choice of each treatment options requires the evaluation of risks and benefits, and often this evaluation is entrusted to the doctor, who will have to see if there are indications for surgery. The "Proportion of transurethral prostatectomy for benign hyperplasia of total prostatectomy" measures the number of prostatectomies for which there not seems to be a clear indication for the total of all prostatectomies performed in a facility. The indicator "Hospitalization for transurethral prostatectomy for benign prostate hyperplasia" allow to measure the variability of hospitalization rates between geographic areas and to identify potential overuse or under use of the surgical technique, since it is unlikely that the indications for TURP may vary systematically between the areas considered. For more informations: http://95.110.213.190/prevale2014/